New Legislation Would Boost FDA Oversight of Compounding Pharmacies, Track Rx Drugs
On Wednesday, a bipartisan group of lawmakers in the House and Senate announced an agreement on legislation that would give FDA greater authority to regulate compounding pharmacies and implement an electronic system to track pharmaceuticals though the distribution chain. The new bill -- called the Drug Quality and Security Act -- would allow FDA to track drugs that compounding pharmacies are making, receive reports about problems with the compounded drugs and have authority to conduct safety inspections, among other regulatory powers.
- "U.S. Congressional Panels Agree on Bill To Regulate Drug Compounding" (Clarke, Reuters, 9/25).
- "Bill Would Toughen Compounding Pharmacy Oversight" (LeBlanc, AP/Atlanta Journal-Constitution, 9/25).